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Objective: We sought to investigate the effects of myocardial ischemic precondi-
tioning in adult and aged patients undergoing coronary artery bypass grafting.
Methods: Eighty patients with 3-vessel disease undergoing coronary artery bypass
grafting were randomized into one of the following groups: adult ischemic precon-
ditioning, adult control, aged ischemic preconditioning, and aged control.
Hemodynamic data and cardiac troponin I values were compared between the
groups. The ischemic preconditioning groups received 2 periods of 2 minutes of
ischemia, followed by 3 minutes of reperfusion. The Student t test, χ2 test, and
analysis of variance for repeated measures were used for the statistical analysis.
Results: The baseline for right ventricular ejection fraction and cardiac index was
similar. Right ventricular ejection fraction was depressed after the operation in all
groups. Ischemic preconditioning significantly improved the recovery of right ven-
tricular ejection fraction and cardiac index after the operation in adult patients (P =
.013 and .001, respectively), but in the aged group there was no difference in the
changes of ejection fraction and cardiac index (P = .232 and .889, respectively). The
cardiac troponin I value in the adult patients subjected to ischemic preconditioning
was lower than that in the adult control subjects (P = .046), but in aged patients
undergoing ischemic preconditioning, the value was similar to that in aged control
subjects (P = .897). Ischemic preconditioning also resulted in a shorter postopera-
tive mechanical ventilation time and in less inotropic use in the adult group.
Conclusion: Ischemic preconditioning protects the heart from ischemic reperfusion
injury in adult patients undergoing coronary artery bypass grafting. The beneficial
effects of ischemic preconditioning are manifested as a better recovery of right ven-
tricular and global hemodynamic function, cellular viability, and surgical outcome.
The protective effect of ischemic preconditioning is diminished in aged patients
undergoing coronary bypass.
Myocardial ischemic preconditioning (IP) has been extensivelystudied in various kinds of experimental models, as well as inhuman subjects. It has proved a potent endogenous factor inpreserving high-energy phosphates, suppressing arrhythmias,delaying myocardial infarction, and improving postischemicfunctional recovery.1,2 Different experimental models and
conditions simulating cardiac surgery have also been investigated.2,3
Published reports on the IP protective effects in the aged heart are controversial.
Animal model studies show that the effect is lost in the senescent4 or even middle-
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aged rat heart,5 whereas in senescent sheep (5.7-8.0 years)
the response is well conserved.6 Abete and colleagues7
found that the angina-induced IP protection against myocar-
dial infarction was lost in aged patients. Warm-up phenom-
enon, a counterpart of IP, can be observed in adult, but not
in older, patients.8 A recent report shows that exercise-
induced IP protects the following ischemia, but it only
occurs in adult, and not in elderly, patients; this reinforces
the hypothesis of an age-related reduction of IP in the aged
heart.9 However, Kloner and colleagues10 have shown that
the protective effect of preinfarct angina to the subsequent
myocardial infarction persists also in patients aged 60 years
or older.
More recently, articles report the application of IP in car-
diopulmonary bypass (CPB) surgery. The outcome, however,
has been controversial. Differences in study protocols and
patients might be the reason for the discrepancies (Table 1).11-21
No investigation of the age-related aspects of the IP phenom-
enon has been made in human cardiac surgery to our knowl-
edge. The aim of the present study was to investigate the
myocardial performance after IP in differently aged patients
undergoing coronary artery bypass grafting (CABG).
Materials and Methods
The study design was accepted by the Ethical Committee of
Tampere University Hospital, Finland, and informed consent was
obtained from all patients.
Patients
Eighty patients with 3-vessel coronary artery disease undergoing
CABG were randomized into an IP group (n = 40) and a control
group (n = 40). According to the median age (68 years), patients were
further divided into an adult IP group and an adult control group (<68
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years) and an aged IP group and an aged control (≥68 years). Patients
with low ejection fractions (<35%), recent myocardial infarction (<3
months), additional cardiac diseases, severe noncardiac diseases, and
calcified or severely dilated ascending aortas were excluded.
The preoperative data of the patients were similar between the IP
and the control groups. There were no statistically significant differ-
ences in age, sex, New York Heart Association class, left ventricular
ejection fraction, vessel diseases, previous myocardial infarction,
left ventricular hypertrophy, diabetes, or preoperative medication
use between the 2 groups. The numbers of vessels bypassed, cross-
clamping time, and CPB time were also similar (Table 2).
Preconditioning Protocol
After establishing CPB and running the pump to empty the heart,
the ascending aorta was occluded by means of crossclamping for 2
minutes, followed by 3 minutes of reperfusion; the procedure was
repeated once. In the control group the pump was also run for 10
minutes before routine operation. Normothermia was maintained
during the procedure.
Anesthesia, CPB, and Surgical Technique
A standardized anesthetic technique was used with sufentanil,
midazolam, and pancuronium bromide. CPB with nonpulsatile
perfusion flow (2.2-2.4 L · min–1 · m–2) was conducted by using
membrane oxygenators with arterial line filtration. Mild hypother-
mia (32°C) was maintained without topical cooling. Blood from
the pump reservoir was mixed with crystalloid in a ratio of 4:1,
yielding a cardioplegia solution with a 0.21 hematocrit value and a
21 mmol/L potassium concentration in the initial dose and 9
mmol/L in subsequent doses. In antegrade delivery cardioplegia
was administered at a pressure of 80 mm Hg, and in retrograde
delivery it was administered at a pressure of 30 to 40 mm Hg, with
a flow of at least 200 mL/min. The initial high-potassium cardio-
plegia was given for 1.5 minutes in an antegrade fashion and then
for 2.5 minutes in a retrograde fashion at a temperature of 6°C to
9°C. Reinfusion of cardioplegia was administered for 1 minute
TABLE 1. Reports of IP in cardiac surgery
Authors Age of patients (y) IP protocol Results
Yellon and coworkers12 and 58.0 ± 2.8 2 cycles, 3 min I/2 min R Preserved high-energy phosphate
Alkhulaifi and coworkers13
Lu and coworkers14 31.9 ± 3.6 2 cycles, 2 min I/3 min R Preserved high-energy phosphate, improved heart
performance
Illes and Swoyer15 61.6 ± 1.5 1 cycle, 1 min I/5 min R Improved heart performance, decreased need
for inotropic support
Li and cowrokers16 32 ± 4 2 cycles, 3 min I/2 min R Lower release of CK-MB and better
hemodynamic outcome, increased myocardial
superoxide dismutase and decreased
malondialdehyde activity
Szemagala and coworkers17 56.4 ± 9.2 1 cycle, 4 min I/6 min R Decreased CTnT release
Jenkins and coworkers18 57 ± 2 2 cycles, 2 min I/3 min R Decreased CTnT release
Perrault and coworkers19 68 ± 3 1 cycle, 3 min I/2 min R CK-MB and lactate increased, no clinical
adverse and protective effects
Kaukoranta and coworkers20 63.9 ± 2.1 1 cycle, 5 min I/5 min R No better effect of IP
Cremer and coworkers21 62.1 ± 4.6 2 cycles, 5 min I/10 min R Increased inotropic use
I, Ischemia; R, reperfusion; CK-MB, creatine kinase MB.
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with retrograde delivery and to vein grafts after completion of each
distal vein graft anastomosis. Warm cardioplegia (37°C) was given
in a retrograde fashion for 3 minutes before crossclamp release.
Surgical techniques were the same in all cases. Aortic root and 2-
stage single venous cannulas were used for CPB. Distal anasto-
moses were made in the order of right coronary artery–circumflex
artery–left anterior descending artery. The proximal anastomoses
were constructed in a reverse order and during aortic crossclamp-
ing. The left anterior descending artery was grafted with the left
internal thoracic artery in all patients.
Hemodynamic Measurements and Treatment
Hemodynamic data were collected at 4 time points: (1) baseline
(before induction of anesthesia); (2) 1 hour after declamping; (3) 6
hours after declamping; and (4) on the first postoperative day
(POD). Heart rate (HR), mean arterial pressure (MAP), central
venous pressure (CVP), mean pulmonary artery pressure (MPAP),
pulmonary capillary wedge pressure (PCWP), cardiac output
(CO), and right ventricular ejection fraction (RVEF) were moni-
tored. Derived cardiovascular variables, including cardiac index
(CI) and right ventricular end-diastolic volume index (RVEDVI),
were calculated with standard formulas. All measurements based
on the thermodilution technique were made at end expiration in
triplicate with ice-cold saline solution. The mean value of 3 con-
secutive measurements at each time point was registered.
Perioperatively, volume infusion was designed to maintain fill-
ing pressures at least at the preoperative level and optimal for heart
performance. Inotropes (dopexamine or adrenaline) were used to
maintain the CI above 2.0 L·min–1·m–2. Amrinone with noradrena-
line was used when dopexamine or adrenaline proved insufficient to
maintain the CO. They were applied after release of crossclamping
and continued for at least 6 hours. Inotropes were not discontinued
at the time points when hemodynamic data were measured.
Cardiac Troponin I
Blood samples were collected from peripheral vessels (1) before
CPB as baseline, (2) 5 minutes after declamping, (3) 6 hours after
declamping, (4) at the first POD, and (5) at the second POD.
Samples were collected in heparin-coated plastic tubes and cen-
trifuged. Serum samples were measured with a Chiron ACS180
analyzer (Chiron Diagnostics Corp, East Walpole, Mass) by using
a direct chemiluminescence method.
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Statistics
The 2-sample Student t test (2-tailed) was used for continuous
data. The χ2 or Fisher exact tests were used for categoric data
when comparing variables between the IP and control groups in
the adult or aged patients. Analysis of variance (ANOVA) for
repeated measures was used to test repeated observation variables
after the operation. Data are presented as means ± SD. Statistical
analyses were made with an SPSS/Windows (version 9.0) statisti-
cal package program.
Results
Hemodynamics in Adult Patients
The hemodynamic variables, namely HR, MAP, CVP,
MPAP, PCWP, and RVEDVI, were similar between the IP
and control groups (Table 3). There was no difference
between the IP and control groups in the baseline level of
RVEF (41.2% ± 6.2% vs 44.2% ± 7.0%, P = .167, t test). The
baseline level of CI in the control group had a slight tendency
to be higher than that in the IP patients (2.39 ± 0.37 vs 2.68
± 0.52 L·min–1·m–2 in the IP and control groups, respec-
tively; P = .058, t test). RVEF was depressed after the oper-
ation in both groups, with the depression being milder in the
IP group (P = .013, ANOVA for repeated measures; Figure
1). IP resulted in better recovery of CI after the operation (P
= .001, ANOVA for repeated measures; Figure 2).
Hemodynamics in Aged Patients
The hemodynamic variables, namely HR, MAP, CVP,
MPAP, PCWP, and RVEDVI, were similar between the IP
and control groups (Table 3). The baseline levels of RVEF
and CI were similar between the IP and the control groups
(41.2% ± 6.0% vs 41.0% ± 6.3%, P = .895 and 2.47 ± 0.31
vs 2.41 ± 0.28 L·min–1·m–2, P = .519, respectively, t test). In
the IP group there was a slight tendency toward better
recovery in RVEF immediately after the operation, but it
was not statistically significant (P = .126, ANOVA for
repeated measures; Figure 1). IP did not induce better
recovery of CI after the operation (P = .889, ANOVA for
repeated measures; Figure 2).
Figure 1. RVEF in adult and aged patients undergoing CABG after
operation. Data are presented as means ± SEM.
Figure 2. CI in adult and aged patients undergoing CABG after
operation. Data are presented as means ± SEM.
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Cardiac Troponin I
The baselines of serum cardiac troponin I (CTnI) in the
groups were similar (0.19 ± 0.04 vs 0.19 ± 0.08 µg/L in the
adult IP and control groups, P = .966, and 0.23 ± 0.08 vs
0.15 ± 0.03 µg/L in the aged IP and control groups, P =
.360, respectively, t test). There was a massive release of
CTnI after the operation, and this did not recover until the
second POD. The CTnI values in adult patients undergoing
IP were lower than those in adult control subjects (P = .046,
ANOVA for repeated measures), whereas there was no sta-
tistically significant difference in the CTnI values between
aged patients undergoing IP and control patients (P = .897,
ANOVA for repeated measures; Figure 3).
Surgical Outcome
The period of mechanical ventilation was significantly shorter
in adult patients undergoing IP than in adult control subjects
(P = .030, t test). There was no statistical significance in the
period of mechanical ventilation between the aged IP and the
aged control subjects (P = .187, t test). The length of stay in
the intensive care unit was similar between the groups. More
patients in the adult group undergoing IP were free of
inotropes (P = .043, Fisher exact test), and the period of
inotropic medication was also shorter than that in adult control
subjects (P = .031, t test). The difference in inotropic support
in the aged patients was similar in those undergoing IP and the
control subjects (Table 4). There was no perioperative myocar-
dial infarction. No intra-aortic balloon pump was used.
Discussion
Myocardial IP has been extensively studied in various kinds
of experimental models, as well as in human subjects.1-3
However, reports on the IP effects in cardiac surgery are few
in number. There are several studies showing that IP is effec-
tive in preserving high-energy phosphate,12-14 improving
heart performance,14-16 reducing CTnI release,17,18 and
increasing myocardial superoxide dismutase and decreasing
malondialdehyde activity16 during cardiac surgery. There are
also controversial reports as to the safety and effectiveness of
IP during CPB surgery.19-21 Difference in the IP protocol and
study subjects might be the reason for discrepancy. Age-
TABLE 2. Preoperative data and perioperative course
Adult IP patients Adult control subjects Aged IP patients Aged control subjects
(n = 21) (n = 18) (n = 19) (n = 22)
Age (y) 57.0 ± 8.0 58.9 ± 6.5 71.8 ± 2.7 73.2 ± 3.3
Sex (F/M) 3/18 2/16 6/13 8/14
NYHA class (II, III, or IV) 3.3 ± 0.7 3.6 ± 0.6 3.5 ± 0.5 3.4 ± 0.6
LVEF (%) 60.7 ± 12.4 63.5 ± 8.8 59.4 ± 10.2 62.6 ± 11.5
LAD (stenosis %) 80.0 ± 24.0 82.3 ± 15.4 81.0 ± 16.0 78.7 ± 23.1
LCX (stenosis %) 78.5 ± 23.8 76.5 ± 15.6 81.6 ± 22.8 74.0 ± 7.6
RCA (stenosis %) 84.0 ± 24.8 83.5 ± 17.4 85.0 ± 16.7 76.0 ± 25.7
LM >50% (n) 8 7 8 7
MI history (n) 13 8 7 9
LV hypertrophy (n) 5 3 3 4
Diabetes (n) 5 7 4 4
ACE inhibitor (n) 6 5 3 3
Ca++ antagonist (n) 4 6 8 6
Vessels bypassed (n) 3.9 ± 0.8 3.6 ± 1.0 3.8 ± 0.8 3.6 ± 0.8
Crossclamping (min) 84.0 ± 20.7 77.4 ± 19.3 78.7 ± 14.6 76.4 ± 13.1
CPB time (min) 119.0 ± 20.8 112.5 ± 22.1 110.1 ± 18.9 106.5 ± 18.3
Similar preoperative data and operative courses were found between the IP and control groups both in the adult and aged patients. Data are presented
as means ± SD. NYHA, New York Heart Association; LVEF, left ventricular ejection fraction; LAD, left anterior ascending artery; LCX, left circumflex artery;
RCA, right coronary artery; LM, left main coronary artery; MI, myocardial infarction; LV, left ventricular; ACE, angiotensin-converting enzyme.
Figure 3. CTnI in adult and aged patients undergoing CABG after
operation. Data are presented as means ± SEM.
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related factors may also play an important role.4,5,7-9 As far
as we know, the possible relation of the controversial result
of IP in cardiac surgery has not been studied.
Our present findings suggested that preconditioning with
2 periods of 2-minute ischemia, followed by 3 minutes of
reperfusion, was cardioprotective during CABG operations
with cold-blood cardioplegia in adult patients. These bene-
ficial effects of IP included better recovery of right ventric-
ular function, improved global hemodynamic performance
after the operation, and preserved cellular viability.
There are controversial reports as to whether IP is a phe-
nomenon confined to the young myocardium.4-10 Our
results suggested that the improved hemodynamic outcome
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and cellular viability were indeed closely associated with
the age of the patients undergoing IP. It was clearly demon-
strated that the protective IP effects were not present in aged
patients undergoing CABG, which is in accord with previ-
ous observations of loss of IP in the aged heart.4,5,7-9
The precise mechanism of IP remains unknown. Brief
episodes of myocardial ischemia result in the production of
adenosine, norepinephrine, free radicals, and bradykinin.
These chemical factors act on one or more types of myocyte
receptor (eg, adenosine A1, muscarinic receptor, and α sym-
pathetic receptor) and result in translocation and activation
of tyrosine kinase and protein kinase C to the cellular mem-
brane, working with inhibitory G-protein to subsequently
TABLE 3. Hemodynamic data
Group Baseline 1 h declamping 6 h declamping First POD
HR (beats/min) Adult IP 56.0 ± 11.7 78.5 ± 14.6 86.7 ± 14.4 80.1 ± 10.6
Adult control 60.9 ± 10.1 77.8 ± 17.8 87.0 ± 27.1 84.4 ± 10.3
Aged IP 55.7 ± 6.9 78.3 ± 17.0 87.5 ± 13.6 75.2 ± 8.9
Aged control 59.1 ± 10.7 76.7 ± 13.8 86.2 ± 14.5 80.2 ± 12.6
MAP (mm Hg) Adult IP 87.1 ± 14.5 76.8 ± 9.7 80.2 ± 12.8 77.9 ± 11.7
Adult control 94.0 ± 13.5 78.9 ± 6.7 76.1 ± 11.3 80.4 ± 11.8
Aged IP 88.0 ± 12.3 75.1 ± 9.1 75.9 ± 12.4 74.6 ± 9.1
Aged control 89.4 ± 14.3 75.7 ± 14.3 79.4 ± 11.2 77.2 ± 11.0
CVP (mm Hg) Adult IP 6.6 ± 2.6 9.2 ± 1.9 10.0 ± 2.7 8.8 ± 2.3
Adult control 8.1 ± 2.2 9.4 ± 2.9 10.3 ± 2.8 8.6 ± 3.4
Aged IP 8.1 ± 2.7 10.2 ± 2.0 10.3 ± 2.7 9.1 ± 3.6
Aged control 7.8 ± 2.9 9.9 ± 2.4 11.1 ± 3.3 7.9 ± 2.5
MPAP (mm Hg) Adult IP 19.0 ± 7.2 19.7 ± 8.2 23.1 ± 4.9 21.2 ± 3.8
Adult control 20.3 ± 5.4 20.0 ± 6.0 23.6 ± 5.8 20.6 ± 5.5
Aged IP 20.3 ± 4.9 19.3 ± 3.6 23.1 ± 5.7 20.9 ± 3.9
Aged control 20.6 ± 9.5 20.8 ± 4.4 23.6 ± 5.2 20.5 ± 4.7
PCWP (mm Hg) Adult IP 12.1 ± 3.9 10.4 ± 6.7 11.1 ± 3.1 11.0 ± 2.3
Adult control 13.1 ± 3.5 11.6 ± 3.2 11.2 ± 3.4 10.7 ± 2.9
Aged IP 11.4 ± 3.2 11.3 ± 2.2 10.5 ± 3.5 11.7 ± 2.2
Aged control 12.7 ± 5.9 11.2 ± 2.8 11.4 ± 3.2 11.0 ± 2.3
RVEDVI (mL/m2) Adult IP 103.3 ± 14.8 86.9 ± 20.5 92.5 ± 15.6 98.9 ± 19.3
Adult control 101.1 ± 21.8 82.3 ± 24.2 90.2 ± 24.5 105.5 ± 29.3
Aged IP 106.1 ± 24.2 77.7 ± 11.1 92.1 ± 23.0 96.6 ± 18.0
Aged control 100.6 ± 12.9 85.9 ± 20.6 93.9 ± 27.6 98.0 ± 19.9
There were no statistically significant differences between the IP and control groups in the adult or in the aged patients. Data are presented as means ±
SD.
TABLE 4. Postoperative care
Adult IP Adult control Aged IP Aged control
Mechanical ventilation (h) 11.3 ± 3.5 16.3 ± 9.4* 13.4 ± 3.0 20.1 ± 22.4
Stay in ICU (h) 28.2 ± 17.2 37.4 ± 22.5 40.8 ± 31.5 46.2 ± 41.0
Free of inotropes (n) 11 3* 4 5
Duration of inotropes (h) 6.7 ± 10.2 13.9 ± 9.6* 13.7 ± 9.6 21.3 ± 31.9
Dopexamine or adrenaline (n) 5 10* 10 15
Amrinone-noradrenaline (n) 9 10 11 10
Data are presented as means ± SD. ICU, Intensive care unit.
*P < .05, difference between IP and control group in the same age groups.
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phosphorate the adenosine triphosphate–dependent potas-
sium channel to trigger IP response. Increased release of
one agonist or stimulation by more cycles of brief ischemic
stimuli can compensate for the lack of another to achieve the
protective effect. Protein kinase C translocates from cytosol
to the cell membrane after activation and mediates phos-
phorylation of target proteins, ion channels, and myofila-
ments to achieve the effect. The delayed cardiac adaptation
is consistent with induced gene transcription and the subse-
quent translocation of protective molecular proteins, includ-
ing proto-oncogenes, stress proteins, and antioxidant
enzyme systems.2,22
The aged myocardium evinces decreased adrenergic
responsiveness, altered coronary microcirculation, impaired
calcium transport, and impaired excitation-contraction cou-
pling. Its maximal oxygen uptake decreases, and the rate of
this decline accelerates with age.6,7,23,24 A reduction of nor-
epinephrine release from cardiac adrenergic terminals has
been shown after ischemic reperfusion in older animals.7 It
is also reported that exogenous administration of norepi-
nephrine is able to mimic IP in the senescent heart. The
reduction in norepinephrine release after transient ischemic
stimulus might thus be responsible for the age-related loss of
IP.9 Exercise adaptation has been shown to increase the
expression of the sarcolemmal Ca++ pump protein in the rat
heart. It has been found that there is a reduction in the sar-
colemmal Ca++ pump activity and abnormal sarcoreticular
Ca++ cycling in the aged heart.24 The age-related impairment
of calcium transport and excitation-contraction coupling
might also result in a loss of the protective effect of IP. The
myocardial activity of superoxide dismutase and the produc-
tion of heat-shock protein decline with age,5,7 and these
agents are known to play an important role in the IP mecha-
nism.2,22 Therefore in the aged heart the absence of IP may
be due to the absence of a series of triggers, mediators, and
effectors that are involved in the IP protective mechanism.
A review of studies of IP in cardiac surgery reveals that
the effect of IP might be age related. In the reports that
demonstrate the protective IP phenomenon in cardiac
surgery, the patients have been relatively young. The report
of Illes and Swoyer15 is one with a mean patient age of over
60 years (Table 1). However, the protocol used in that study
to induce the protective effects was much different from that
in the other 3 studies on elderly patients with a mean age of
over 60 years. It has been suggested that the IP stimuli could
have caused cumulative effects in the aged myocardium,
which is more vulnerable to ischemia.7 The IP stimuli
needed to induce a protective effect in adult and aged
patients, respectively, might therefore be different. Further
studies are called for to elucidate this hypothesis.
It is noteworthy that the age definition in the age-related
IP effect is relative rather than absolute. Evidence of the IP
phenomenon in patients at over 60 years of age suggests that
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the potential for IP could still in fact remain in an aged per-
son.10 In the present study the right ventricular function,
which is the most vulnerable in patients with 3-vessel dis-
ease undergoing CABG, tended to recover better in the aged
patients undergoing IP than in control subjects.
Two periods of 2-minute ischemia, followed by 3-minute
reperfusion preconditioning, protects the heart from
ischemic reperfusion injury in adult patients with 3-vessel
coronary artery disease undergoing CABG. The beneficial
effects of IP are manifested in better recovery of right ven-
tricular and global hemodynamic function, better preserved
cellular viability, and better surgical outcome. The protec-
tive effect declines in aged patients undergoing CABG.
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